Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:India
|
| gptkbp:founded |
1993
|
| gptkbp:founder |
gptkb:B._Partha_Saradhi_Reddy
|
| gptkbp:headquarters_location |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hetero Drugs Ltd.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:B._Partha_Saradhi_Reddy
|
| gptkbp:market |
Worldwide
|
| gptkbp:notable_for |
COVID-19 drug Remdesivir production
HIV/AIDS antiretroviral drugs |
| gptkbp:numberOfEmployees |
over 21,000
|
| gptkbp:parentOrganization |
gptkb:Hetero_Group
|
| gptkbp:products |
Active pharmaceutical ingredients
Generic drugs |
| gptkbp:subsidiary |
gptkb:Hetero_Healthcare
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.heteroworld.com/
|
| gptkbp:bfsParent |
gptkb:Priton
|
| gptkbp:bfsLayer |
7
|